Allogeneic Stem Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL) patients <50 years old in first complete remission(CR) A Donor vs no donor comparison in the EORTC ALL-3 Study.

Reviewer: Julie Draznin Maltzman, MD
OncoLink
Ultima Vez Modificado: 9 de diciembre del 2002

Translation for this article does not exist

Blogs

Healing Paws: Claire, Elise, Kim, Don and Finn
by OncoLink Editorial Team
February 09, 2016